sulbenicillin sodium
Commercial- Indications
- Bacterial infections
Company intelligence / Profile preview
Hunan Er-Kang Pharmaceutical is the largest and most comprehensive pharmaceutical excipient company in China. It holds over 90 patents for its starch-based plant capsule technology and has more than 282 finished drug product approvals. The company exports to nearly 40 countries and serves over 4,000 customers worldwide. Its innovative starch capsule platform has global exclusive intellectual property rights[2][3]. The company also produces a wide range of APIs (73+), pharmaceutical excipients (127+), and finished drugs.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Er-Kang Pharmaceutical.